Head & Neck Cancer

From Stand Up to Cancer honoring survivors at a Minor League baseball game, to Maria Menounos showing her cancer scars on Instagram, here’s what’s happening in the oncology space this week.

Patients with advanced cancers who live in states that expanded Medicaid were more likely to receive early palliative care, although utilization remains low in the U.S.

Caregiver burden was prevalent among caregivers of patients with head and neck cancer, due to lack of patient employment and poor health-related quality of life.

A chemotherapy shortage is resulting in altered treatment plans for many patients with cancer. CURE® spoke with experts about what that means for patients — and what they can do about it.

Treatment with a CAR-M cell therapy plus Keytruda is being assessed in a phase 1 study in patients with HER2-overexpressed tumors.

Being overweight might improve overall survival and progression-free survival for patients with head and neck cancer undergoing chemoradiotherapy, recent research showed.

From Shannen Doherty’s announcement that her breast cancer spread to her brain to a nonprofit being established in memory of the late YouTuber, Technoblade, here’s what’s happening in the oncology space this week.

From Edward James Olmos and Khloé Karsashian both discussing their cancer diagnoses to a survivor making a movie musical about her diagnosis and more, here’s what’s happening in the oncology space this week.

From YouTuber Hank Green announcing his lymphoma diagnosis, to Jeff Bridges, Martina Navratilova and Leanne Hainsby giving updates on their cancer, here’s what’s happening in the oncology space this week.

A small survey of women with head and neck cancer found that while many experience physical and emotional distress, social supports can help.

A patient with head and neck cancer highlights the importance of a strong support system throughout the time he was recovering from surgery.

HPV vaccination rates and public knowledge about the connection between the virus and certain cancer types are below what they should be, research found.

Researchers conducting the VISTA-101 study will assess the safety and efficacy of KVA12123 alone and with Keytruda, in addition to determining the recommended dose of the therapy.

I had what I thought was a canker sore that didn't heal. It ended up being cancer.

From Sam Neill announcing his cancer diagnosis to Martina Navratilova stating that she is now cancer-free, here’s what’s happening in the oncology space this week.

A recent study finds patients who test positive for an HPV biomarker may not be positive for HPV itself, and these patients see significantly lower five-year survival rates.

After being diagnosed with a rare cancer, I met some amazing people and have a new appreciation for life.

How do survivors of head and neck cancer cope with drastic changes to one of the most visibly identifiable body parts — the head?

When I sit down with my paint brush, despite my cancer history, I don’t feel different anymore.

The Food and Drug Administration agreed to speed up the review of avasopasem to treat severe oral mucositis in patients with head and neck cancer.

Patients who are looking to quit smoking to better their survival and health outcomes should talk to their health care team about different methods to do so, an expert said.

Opdivo — even when given in a low dose — was shown to improve outcomes in patients with advanced head and neck squamous cell carcinoma, highlighting a new option for patients who cannot receive the full dose.

From tennis star Martina Navratilova’s two cancer diagnoses to First Lady Jill Biden undergoing Mohs surgery to have a suspicious lesion removed and musician deaths, here’s what’s happening in the cancer space this week.

A novel three-drug combination bested standard-of-care regimens for patients with human papillomavirus-related cancers, according to phase 2 study results.

From the singer of “Duran Duran” revealing his stage 4 cancer diagnosis — and missing the band’s induction to the Rock & Roll Hall of Fame because of it — to Barry Corbin’s oral cancer fears, here’s what’s happening in the oncology space this week.

NC410 plus Keytruda will be studied in a phase 1b/2 trial for patients with certain solid cancers that either did not respond to or have not been treated with an immunotherapy agent.

The FDA granted a fast track designation to an investigational drug alone and in combination with Keytruda to treat patients with HPV recurrent/metastatic head and neck squamous cell carcinoma.

Compared with surgery, active surveillance was just as effective and lowered anxiety levels in patients with low-risk papillary thyroid cancer.

The novel drug PY159 will be studied as a single agent and in combination with Keytruda for patients with certain solid tumors — including ovarian, pancreatic, lung, head and neck, colorectal and breast cancers.

Years ago, the goal of head and neck cancer treatment was strictly focused on a cure. Now, there has been a slight change in approach to improve survival rates while preserving quality of life.